Balchem Corporation  

(Public, NASDAQ:BCPC)   Watch this stock  
Find more results for BCPC
57.31
-0.65 (-1.12%)
After Hours: 57.31 0.00 (0.00%)
Jun 28, 4:39PM EDT  
NASDAQ real-time data - Disclaimer
Currency in USD
Range 57.05 - 58.97
52 week 51.88 - 70.91
Open 58.43
Vol / Avg. 110,948.00/120,365.00
Mkt cap 1.77B
P/E 32.23
Div/yield 0.34/0.59
EPS 1.78
Shares 31.57M
Beta 0.71
Inst. own 86%
Aug 2, 2016
Q2 2016 Balchem Corp Earnings Release (Estimated) - 9:30AM EDT - Add to calendar
Jun 16, 2016
Balchem Corp Annual Shareholders Meeting (Estimated)
Jun 15, 2016
Balchem Corp Annual Shareholders Meeting
May 10, 2016
Q1 2016 Balchem Corp Earnings Call
May 10, 2016
Q1 2016 Balchem Corp Earnings Release
More events from DailyFinance »    

Key stats and ratios

Q1 (Mar '16) 2015
Net profit margin 8.80% 10.81%
Operating margin 14.78% 17.01%
EBITD margin - 24.30%
Return on average assets 5.15% 6.86%
Return on average equity 10.10% 13.96%
Employees 875 -
CDP Score - -

Address

P O Box 600
NEW HAMPTON, NY 10958
United States - Map
+1-845-3265632 (Phone)
+1-845-3265742 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

Balchem Corporation (Balchem) is engaged in the development, manufacture, distribution and marketing of specialty performance ingredients and products for the food, nutritional, feed, pharmaceutical and medical sterilization industries. The Company operates in four segments: SensoryEffects, Animal Nutrition & Health (ANH), Specialty Products and Industrial Products. Its SensoryEffects segment provides creamer systems, dairy replacers, powdered fats, nutritional beverage bases, beverages, juice and dairy bases, chocolate systems, ice cream bases and variegates, grain-based snacks and cereal-based ingredients. ANH segment provides basic choline chloride, and microencapsulation and chelation technologies-based nutritional products. Specialty Products segment provides ethylene oxide and propylene oxide products. Its Industrial Products segment provides Choline Chloride and methylamines. The Company sells its products through its own sales force, independent distributors and sales agents.

Officers and directors

Theodore L. Harris President, Chief Executive Officer, Director
Age: 49
Bio & Compensation  - Reuters
William A. Backus CPA Chief Financial Officer
Age: 49
Bio & Compensation  - Reuters
David F. Ludwig Vice President, General Manager- Specialty Products, Executive Officer
Age: 57
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Francis J. Fitzpatrick CPA Vice President - Administration
Age: 54
Bio & Compensation  - Reuters
Matthew D. Houston General Counsel, Secretary
Age: 51
Bio & Compensation  - Reuters
John Y. Televantos Ph.D. Lead Independent Director
Age: 62
Bio & Compensation  - Reuters
Matthew D. Wineinger Director
Age: 44
Bio & Compensation  - Reuters
Paul D. Coombs Independent Director
Age: 59
Bio & Compensation  - Reuters
David B. Fischer Independent Director
Age: 53
Bio & Compensation  - Reuters
Edward L. McMillan Independent Director
Age: 69
Bio & Compensation  - Reuters